494 related articles for article (PubMed ID: 15753359)
1. Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis.
Shidara Y; Yamagata K; Kanamori T; Nakano K; Kwong JQ; Manfredi G; Oda H; Ohta S
Cancer Res; 2005 Mar; 65(5):1655-63. PubMed ID: 15753359
[TBL] [Abstract][Full Text] [Related]
2. Contribution of somatic mutations in the mitochondrial genome to the development of cancer and tolerance against anticancer drugs.
Ohta S
Oncogene; 2006 Aug; 25(34):4768-76. PubMed ID: 16892089
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the mitochondrial genome confer resistance of cancer cells to anticancer drugs.
Mizutani S; Miyato Y; Shidara Y; Asoh S; Tokunaga A; Tajiri T; Ohta S
Cancer Sci; 2009 Sep; 100(9):1680-7. PubMed ID: 19555391
[TBL] [Abstract][Full Text] [Related]
4. mtDNA mutations increase tumorigenicity in prostate cancer.
Petros JA; Baumann AK; Ruiz-Pesini E; Amin MB; Sun CQ; Hall J; Lim S; Issa MM; Flanders WD; Hosseini SH; Marshall FF; Wallace DC
Proc Natl Acad Sci U S A; 2005 Jan; 102(3):719-24. PubMed ID: 15647368
[TBL] [Abstract][Full Text] [Related]
5. Metabolic rescue in pluripotent cells from patients with mtDNA disease.
Ma H; Folmes CD; Wu J; Morey R; Mora-Castilla S; Ocampo A; Ma L; Poulton J; Wang X; Ahmed R; Kang E; Lee Y; Hayama T; Li Y; Van Dyken C; Gutierrez NM; Tippner-Hedges R; Koski A; Mitalipov N; Amato P; Wolf DP; Huang T; Terzic A; Laurent LC; Izpisua Belmonte JC; Mitalipov S
Nature; 2015 Aug; 524(7564):234-8. PubMed ID: 26176921
[TBL] [Abstract][Full Text] [Related]
6. Rescue of a deficiency in ATP synthesis by transfer of MTATP6, a mitochondrial DNA-encoded gene, to the nucleus.
Manfredi G; Fu J; Ojaimi J; Sadlock JE; Kwong JQ; Guy J; Schon EA
Nat Genet; 2002 Apr; 30(4):394-9. PubMed ID: 11925565
[TBL] [Abstract][Full Text] [Related]
7. Specific mtDNA mutations in mouse carcinoma cells suppress their tumor formation via activation of the host innate immune system.
Imanishi H; Takibuchi G; Kobayashi T; Ishikawa K; Nakada K; Mori M; Kikkawa Y; Takenaga K; Toyama-Sorimachi N; Hayashi J
PLoS One; 2013; 8(9):e75981. PubMed ID: 24098752
[TBL] [Abstract][Full Text] [Related]
8. Changes in mitochondrial DNA alter expression of nuclear encoded genes associated with tumorigenesis.
Jandova J; Janda J; Sligh JE
Exp Cell Res; 2012 Oct; 318(17):2215-25. PubMed ID: 22705584
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial ND5 gene variation associated with encephalomyopathy and mitochondrial ATP consumption.
McKenzie M; Liolitsa D; Akinshina N; Campanella M; Sisodiya S; Hargreaves I; Nirmalananthan N; Sweeney MG; Abou-Sleiman PM; Wood NW; Hanna MG; Duchen MR
J Biol Chem; 2007 Dec; 282(51):36845-52. PubMed ID: 17940288
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic transfer of the mtDNA nt 8993 T-->G (ATP6) point mutation associated with Leigh syndrome into mtDNA-less cells demonstrates cosegregation with a decrease in state III respiration and ADP/O ratio.
Trounce I; Neill S; Wallace DC
Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8334-8. PubMed ID: 8078883
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial DNA mutation and depletion increase the susceptibility of human cells to apoptosis.
Liu CY; Lee CF; Hong CH; Wei YH
Ann N Y Acad Sci; 2004 Apr; 1011():133-45. PubMed ID: 15126291
[TBL] [Abstract][Full Text] [Related]
12. Enhanced tumorigenicity by mitochondrial DNA mild mutations.
Cruz-Bermúdez A; Vallejo CG; Vicente-Blanco RJ; Gallardo ME; Fernández-Moreno MÁ; Quintanilla M; Garesse R
Oncotarget; 2015 May; 6(15):13628-43. PubMed ID: 25909222
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment.
Arnold RS; Sun CQ; Richards JC; Grigoriev G; Coleman IM; Nelson PS; Hsieh CL; Lee JK; Xu Z; Rogatko A; Osunkoya AO; Zayzafoon M; Chung L; Petros JA
Prostate; 2009 Jan; 69(1):1-11. PubMed ID: 18850577
[TBL] [Abstract][Full Text] [Related]
14. Increases of mitochondrial mass and mitochondrial genome in association with enhanced oxidative stress in human cells harboring 4,977 BP-deleted mitochondrial DNA.
Wei YH; Lee CF; Lee HC; Ma YS; Wang CW; Lu CY; Pang CY
Ann N Y Acad Sci; 2001 Apr; 928():97-112. PubMed ID: 11795533
[TBL] [Abstract][Full Text] [Related]
15. Enhanced generation of mitochondrial reactive oxygen species in cybrids containing 4977-bp mitochondrial DNA deletion.
Jou MJ; Peng TI; Wu HY; Wei YH
Ann N Y Acad Sci; 2005 May; 1042():221-8. PubMed ID: 15965066
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk from non-cancerous mitochondria can inhibit tumor properties of metastatic cells by suppressing oncogenic pathways.
Kaipparettu BA; Ma Y; Park JH; Lee TL; Zhang Y; Yotnda P; Creighton CJ; Chan WY; Wong LJ
PLoS One; 2013; 8(5):e61747. PubMed ID: 23671572
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis in mitochondrial encephalomyopathies with mitochondrial DNA mutations: a potential pathogenic mechanism.
Mirabella M; Di Giovanni S; Silvestri G; Tonali P; Servidei S
Brain; 2000 Jan; 123 ( Pt 1)():93-104. PubMed ID: 10611124
[TBL] [Abstract][Full Text] [Related]
18. A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis.
Park JS; Sharma LK; Li H; Xiang R; Holstein D; Wu J; Lechleiter J; Naylor SL; Deng JJ; Lu J; Bai Y
Hum Mol Genet; 2009 May; 18(9):1578-89. PubMed ID: 19208652
[TBL] [Abstract][Full Text] [Related]
19. Mutations in BALB mitochondrial DNA induce CCL20 up-regulation promoting tumorigenic phenotypes.
Sligh J; Janda J; Jandova J
Mutat Res; 2014 Nov; 769():49-58. PubMed ID: 25177208
[TBL] [Abstract][Full Text] [Related]
20. Maternally-inherited Leigh syndrome-related mutations bolster mitochondrial-mediated apoptosis.
Carrozzo R; Rizza T; Stringaro A; Pierini R; Mormone E; Santorelli FM; Malorni W; Matarrese P
J Neurochem; 2004 Jul; 90(2):490-501. PubMed ID: 15228605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
